Derek Horton

This inventor holds 8 USPTO granted patents. Top assignees: The Ohio State University, The United States of America as Represented by the Department of Health. Active years: 1977-1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Derek Horton. Retrieved from https://idiyas.com/inventor/derek-horton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 47(Granted Patents)

Company Filing History:

5 out of 1,577

The Ohio State University

patents

3 out of 1,217

The United States of America as Represented by the Department of Health

patents

Years Active: 1977-1989

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4870058 - 14-Acyloxy-2'-halo-anthracycline anti-cancer antibiotics (1989-09-26),

2. 4772688 - 14-acyloxy-2'-halo-anthracycline anti-cancer antibiotics (1988-09-20),

3. 4663445 - 1-fluoro, 4-fluoro, and 1,4-difluoro-2'-halo anthracycline antibiotics (1987-05-05),

4. 4562177 - 3'-Amino-2' halo-anthracycline antibiotics (1985-12-31),

5. 4537882 - 4-Demethoxy-3'-desamino-2'-halo-anthracycline and pharmaceutical (1985-08-27),

6. 4427664 - 2'Halo derivatives of daunomycin, desmethoxy daunomycin, adriamycin and (1984-01-24),

7. 4201773 - 7-O-(2,6-Dideoxy-.alpha.-L-lyxo-hexopyranosyl)-daunomycinone, desmethoxy (1980-05-06),

8. 4024333 - Synthesis of daunosamine hydrochloride from a D-mannose starting material (1977-05-17),

Title: The Innovative Contributions of Derek Horton

Introduction

Derek Horton is a notable inventor based in Columbus, OH (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-cancer antibiotics. With a total of 8 patents to his name, his work has had a profound impact on medical research and treatment options.

Latest Patents

One of Derek Horton's latest patents includes the invention of 14-Acyloxy-2'-halo-anthracycline anti-cancer antibiotics. This patent discloses compounds of the formula (I) and pharmaceutical preparations containing the same. The compounds are characterized by specific chemical structures where R.sup.1 is --OOCR.sup.3 or --OOC(CH.sub.2).sub.n COOR.sup.4, and R.sup.2 can be hydrogen, hydroxy, or methoxy. The invention highlights the potential of these compounds in the inhibition of malignant diseases, showcasing their importance in cancer treatment.

Career Highlights

Derek Horton has worked with prestigious institutions such as The Ohio State University and the United States of America as represented by the Department of Health. His career reflects a commitment to advancing medical science and improving therapeutic options for patients.

Collaborations

Throughout his career, Derek has collaborated with esteemed colleagues, including Waldemar A Priebe and Wolfgang Weckerle. These partnerships have contributed to the success and innovation of his research endeavors.

Conclusion

Derek Horton is a distinguished inventor whose work in anti-cancer antibiotics has made a significant impact on the medical field. His innovative contributions continue to inspire advancements in pharmaceutical research and development.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]